By ALICIA MUNDY And BRENT KENDALL WASHINGTON—A longtime chemist at the Food and Drug Administration was charged Tuesday with insider trading by federal authorities, who alleged he made as much as $3.6 million trading drug company stocks based on confidential drug-approval information. The Securities and Exchange Commission filed civil charges against Cheng Yi Liang, 57, […]
Archives for April 2011
Pneumococcus: Penicillin to Prevnar
By Dr. F. Edward Yazbak Performance and Problems The abuse of penicillin and other antibiotics has led to the proliferation of resistant strains of Streptococcus pneumoniae (pneumococcus). The wide use of Prevnar, a pediatric pneumococcal 7-valent conjugate vaccine, since 2000 is now resulting in problems that could have been anticipated and should now be disclosed. […]
Gardasil and Cervarix: Are strains targeted by the vaccines replaced by other HPV viruses?
By Leslie Carol Botha (NaturalNews) Immunologist Charlotte Haug, MD PhD, MSc and Editor-in-Chief, Tidsskrift for Den norske legeforening (The Journal of the Norwegian Medical Association) raises an interesting question that has yet to be considered by the FDA, CDC or the medical community. What happens if other strains of HPV replace strains 16 or 18 […]
HHS Launches New Consumer-Focused Immunization Website
WASHINGTON–(BUSINESS WIRE)–The U.S. Department of Health and Human Services today unveiled an innovative new website to help parents and other consumers learn about the most effective way to protect themselves and their children from infectious diseases and learn about immunization. Vaccines.gov brings together the best in federal resources on vaccine and immunizations to provide consumers […]
Insider-Trading Case Puts Focus on Key FDA System
By Alicia Mundy As Food and Drug Administration officials examine internal controls in the wake of insider-trading charges filed against a longtime employee, a primary challenge will be how to limit access to valuable information without clogging up the approval process. The computer database that chemist Cheng Yi Liang is accused of exploiting to make […]